Summary
Latest filing:
Susan Dana Jones is Chief Technology Officer of Tourmaline Bio, Inc. (TRML). 1 SEC Form 4 filing on record, dated 28 October 2025.
Recent Transactions
2Every recent SEC Form 4 transaction Susan Dana Jones has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Susan Dana Jones's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Keith S. Manchester - $154.47M of ROIV open-market activity in the last 12 months
- Daniel Allen Gold - $147.38M of ROIV open-market activity in the last 12 months
- QVT Financial LP - $147.38M of ROIV open-market activity in the last 12 months
- ULSE Inc. - $146.25M of ULS open-market activity in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M of KLRA open-market activity in the last 12 months
- Andrew T. Kaplan - $134.38M of KLRA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Susan Dana Jones?
Susan Dana Jones is a corporate insider, tracked as Chief Technology Officer of Tourmaline Bio, Inc. (TRML). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Susan Dana Jones last file a Form 4?
The only primary Form 4 on record is dated 28 October 2025.
Where can I see all of Susan Dana Jones's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Susan Dana Jones and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
